The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques

LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.

Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605 · see citing works

β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 4× · see citing works

Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 2× · see citing works

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849 · see citing works

APP Processing and Synaptic Function

Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · see citing works

Purification and cloning of amyloid precursor protein β-secretase from human brain

Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., et al. (1999) · Nature · doi:10.1038/990114 · Cited by 1,612 · see citing works

Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study

Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588 · see citing works

Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity

Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashler, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., et al. (1999) · Nature · doi:10.1038/990107 · Cited by 1,438 · see citing works

Tor, a Phosphatidylinositol Kinase Homologue, Controls Autophagy in Yeast

Noda, T., & Ohsumi, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3963 · Cited by 1,308 · see citing works

Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo

Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265 · see citing works

Trehalose, a Novel mTOR-independent Autophagy Enhancer, Accelerates the Clearance of Mutant Huntingtin and α-Synuclein

Sarkar, S., Davies, J. E., Huang, Z., Tunnacliffe, A., & Rubinsztein, D. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609532200 · Cited by 1,142 · see citing works

Amyloid Precursor Protein Trafficking, Processing, and Function

Thinakaran, G., & Koo, E. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800019200 · Cited by 1,141 · see citing works

Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy

Tanida, I., Minematsu-Ikeguchi, N., Ueno, T., & Kominami, E. (2005) · Autophagy · doi:10.4161/auto.1.2.1697 · Cited by 1,108 · see citing works

Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase

Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., Gloger, I. S., Murphy, K. E., Southan, C. D., Ryan, D. M., et al. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0811 · Cited by 1,080 · see citing works

Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease

Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M., Schmidt, S. D., Lee, J.-H., Mohan, P. S., Mercken, M., Farmery, M. R., Tjernberg, L. O., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505082 · Cited by 967 · see citing works

The secretases: enzymes with therapeutic potential in Alzheimer disease

De Strooper, B., Vassar, R., & Golde, T. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.218 · Cited by 799 · see citing works

Autophagy: assays and artifacts

Barth, S., Glick, D. R., & Macleod, K. F. (2010) · The Journal of Pathology · doi:10.1002/path.2694 · Cited by 794 · see citing works

Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein

Lin, X., Koelsch, G., Wu, S., Downs, D., Dashti, A., & Tang, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1456 · Cited by 769 · see citing works

The Pathogenesis of Senile Plaques

DICKSON, D. W. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199704000-00001 · Cited by 753 · see citing works

Autophagy, amyloidogenesis and Alzheimer disease

Nixon, R. A. (2007) · Journal of Cell Science · doi:10.1242/jcs.019265 · Cited by 749 · see citing works

Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus

Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2692-08.2008 · Cited by 740 · see citing works

Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.

Koo, E. H., Sisodia, S. S., Archer, D. R., Martin, L. J., Weidemann, A., Beyreuther, K., Fischer, P., Masters, C. L., & Price, D. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1561 · Cited by 733 · see citing works

Control of Peripheral Nerve Myelination by the ß-Secretase BACE1

Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C., & Haass, C. (2006) · Science · doi:10.1126/science.1132341 · Cited by 703 · see citing works

β-Secretase Protein and Activity Are Increased in the Neocortex in Alzheimer Disease

Fukumoto, H. (2002) · Archives of Neurology · doi:10.1001/archneur.59.9.1381 · Cited by 695 · see citing works

Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo

Cirrito, J. R., Kang, J.-E., Lee, J., Stewart, F. R., Verges, D. K., Silverio, L. M., Bu, G., Mennerick, S., & Holtzman, D. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.02.003 · Cited by 635 · see citing works

Bace1 modulates myelination in the central and peripheral nervous system

Hu, X., Hicks, C. W., He, W., Wong, P., Macklin, W. B., Trapp, B. D., & Yan, R. (2006) · Nature Neuroscience · doi:10.1038/nn1797 · Cited by 608 · see citing works

Development of the mossy fibers of the dentate gyrus: I. A light and electron microscopic study of the mossy fibers and their expansions

Amaral, D. G., & Dent, J. A. (1981) · The Journal of Comparative Neurology · doi:10.1002/cne.901950106 · Cited by 606 · see citing works

The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic Potential

Vassar, R., Kovacs, D. M., Yan, R., & Wong, P. C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3657-09.2009 · Cited by 577 · see citing works

Increased expression of the amyloid precursor β‐secretase in Alzheimer's disease

Holsinger, R. M. D., McLean, C. A., Beyreuther, K., Masters, C. L., & Evin, G. (2002) · Annals of Neurology · doi:10.1002/ana.10208 · Cited by 562 · see citing works

BACE1 Deficiency Rescues Memory Deficits and Cholinergic Dysfunction in a Mouse Model of Alzheimer's Disease

Ohno, M., Sametsky, E. A., Younkin, L. H., Oakley, H., Younkin, S. G., Citron, M., Vassar, R., & Disterhoft, J. F. (2004) · Neuron · doi:10.1016/s0896-6273(03)00810-9 · Cited by 549 · see citing works

Synapse Formation and Function Is Modulated by the Amyloid Precursor Protein

Priller, C., Bauer, T., Mitteregger, G., Krebs, B., Kretzschmar, H. A., & Herms, J. W. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1450-06.2006 · Cited by 548 · see citing works

BACE1, a Major Determinant of Selective Vulnerability of the Brain to Amyloid-β Amyloidogenesis, is Essential for Cognitive, Emotional, and Synaptic Functions

Laird, F. M., Cai, H., Savonenko, A. V., Farah, M. H., He, K., Melnikova, T., Wen, H., Chiang, H.-C., Xu, G., Koliatsos, V. E., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2766-05.2005 · Cited by 521 · see citing works

γ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in?

Sisodia, S. S., & St George-Hyslop, P. H. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn785 · Cited by 512 · see citing works

Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients

Li, R., Lindholm, K., Yang, L., Yue, X., Citron, M., Yan, R., Beach, T. G., Sue, L. I., Sabbagh, M. N., Cai, H., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0205689101 · Cited by 493 · see citing works

Lysosomal Proteolysis Inhibition Selectively Disrupts Axonal Transport of Degradative Organelles and Causes an Alzheimer's-Like Axonal Dystrophy

Lee, S., Satō, Y., & Nixon, R. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6412-10.2011 · Cited by 471 · see citing works

Axonal Transport Defects in Neurodegenerative Diseases

Morfini, G. A., Burns, M. R., Binder, L. I., Kanaan, N. M., LaPointe, N. E., Bosco, D. A., Brown, R. H., Brown, H. E., Tiwari, A., Hayward, L. J., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3463-09.2009 · Cited by 464 · see citing works

Phosphorylation of the Translation Initiation Factor eIF2α Increases BACE1 Levels and Promotes Amyloidogenesis

O’Connor, T., Sadleir, K. R., Maus, E., Velliquette, R. A., Zhao, J., Cole, S. L., Eimer, W. A., Hitt, B. D., Bembinster, L. A., Lammich, S., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.047 · Cited by 422 · see citing works

Three‐dimensional analysis of the structure and composition of CA3 branched dendritic spines and their synaptic relationships with mossy fiber boutons in the rat hippocampus

Chicurel, M. E., & Harris, K. M. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903250204 · Cited by 417 · see citing works

Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein and Alzheimer’s Disease

Masliah, E., Sisk, A., Mallory, M. E., Mucke, L., Schenk, D., & Games, D. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-18-05795.1996 · Cited by 387 · see citing works

β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer's Disease Pathogenesis

Zhao, J., Fu, Y., Yasvoina, M., Shao, P., Hitt, B., O'Connor, T., Logan, S., Maus, E., Citron, M., Berry, R., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4396-06.2007 · Cited by 365 · see citing works

Phenotypic and Biochemical Analyses of BACE1- and BACE2-deficient Mice

Dominguez, D. I., Tournoy, J., Hartmann, D., Huth, T., Cryns, K., Deforce, S., Serneels, L., Espuny-Camacho, I., Marjaux, E., Craessaerts, K., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505249200 · Cited by 359 · see citing works

Biology and pathophysiology of the amyloid precursor protein

Zheng, H., & Koo, E. H. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-27 · Cited by 346 · see citing works

Depletion of GGA3 Stabilizes BACE and Enhances β-Secretase Activity

Tesco, G., Koh, Y. H., Kang, E. L., Cameron, A. N., Das, S., Sena-Esteves, M., Hiltunen, M., Yang, S.-H., Zhong, Z., Shen, Y., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.012 · Cited by 337 · see citing works

Endogenous amyloid‐β is necessary for hippocampal synaptic plasticity and memory

Puzzo, D., Privitera, L., Fà, M., Staniszewski, A., Hashimoto, G., Aziz, F., Sakurai, M., Ribé, E. M., Troy, C. M., Mercken, M. H., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22313 · Cited by 320 · see citing works

Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons

Kuhn, P., Koroniak–Szejn, K., Hogl, S., Colombo, A. V., Zeitschel, U., Willem, M., Volbracht, C., Schepers, U., Imhof, A., Hoffmeister, A., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.173 · Cited by 318 · see citing works

Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.

Cras, P. P., Kawai, M., Lowery, D. E., Gonzalez‐DeWhitt, P. A., Greenberg, B., & Perry, G. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7552 · Cited by 314 · see citing works

BACE1 regulates voltage-gated sodium channels and neuronal activity

Kim, D. Y., Carey, B. W., Wang, H., Ingano, L. A. M., Binshtok, A. M., Wertz, M. H., Pettingell, W. H., He, P., Lee, V. M. ‐., Woolf, C. J., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1602 · Cited by 301 · see citing works

Autophagic degradation of tau in primary neurons and its enhancement by trehalose

Krüger, U., Wang, Y., Kumar, S., & Mandelkow, E.-M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.009 · Cited by 297 · see citing works

β Subunits of Voltage-gated Sodium Channels Are Novel Substrates of β-Site Amyloid Precursor Protein-cleaving Enzyme (BACE1) and γ-Secretase

Wong, H. K., Sakurai, T., Oyama, F., Kaneko, K., Wada, K., Miyazaki, H., Kurosawa, M., Strooper, B. D., Säftig, P., & Nukina, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414648200 · Cited by 290 · see citing works

Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in <i>BACE1</i> -null mice

Savonenko, A. V., Melnikova, T., Laird, F. M., Stewart, K.-A., Price, D. L., & Wong, P. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710373105 · Cited by 290 · see citing works

BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice

Ohno, M., Cole, S. L., Yasvoina, M., Zhao, J., Citron, M., Berry, R., Disterhoft, J. F., & Vassar, R. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.008 · Cited by 290 · see citing works

Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system

Sisodia, S., Koo, E., Hoffman, P., Perry, G. L., & Price, D. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-07-03136.1993 · Cited by 284 · see citing works

Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice

Blanchard, V., Moussaoui, S., Czech, C., Touchet, N., Bonici, B., Planche, M., Canton, T., Jedidi, I., Gohin, M., Wirths, O., et al. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00252-8 · Cited by 283 · see citing works

Alzheimer's β-secretase, β-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase

Kitazume, S., Tachida, Y., Oka, R., Shirotani, K., Saido, T. C., & Hashimoto, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241509198 · Cited by 277 · see citing works

Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease.

Cataldo, A. M., Paskevich, P. A., Kominami, E., & Nixon, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.10998 · Cited by 267 · see citing works

The Cell Adhesion Protein P-selectin Glycoprotein Ligand-1 Is a Substrate for the Aspartyl Protease BACE1

Lichtenthaler, S. F., Dominguez, D.-I., Westmeyer, G. G., Reiß, K., Haass, C., Säftig, P., Strooper, B. D., & Seed, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303861200 · Cited by 256 · see citing works

The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel β-Secretase (BACE1) Substrate

Arnim, C. A. F. V., Kinoshita, A., Peltan, I. D., Tangredi, M. M., Herl, L. D., Lee, B. M., Spoelgen, R., Hshieh, T. T., Ranganathan, S., Battey, F. D., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414248200 · Cited by 255 · see citing works

Structural determinants of transmission at large hippocampal mossy fiber synapses

Rollenhagen, A., Sätzler, K., Rodríguez, E. P., Jonas, P., Frotscher, M., & Lübke, J. H. R. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1946-07.2007 · Cited by 246 · see citing works

Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer’s mice hippocampus

Sanchez-Varo, R., Trujillo-Estrada, L., Sanchez-Mejias, E., Torres, M., Baglietto-Vargas, D., Moreno-Gonzalez, I., De Castro, V., Jimenez, S., Ruano, D., Vizuete, M., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0896-x · Cited by 222 · see citing works

Cleavage of Amyloid-β Precursor Protein and Amyloid-β Precursor-like Protein by BACE 1

Li, Q., & Südhof, T. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310001200 · Cited by 219 · see citing works

The Proteolytic Processing of the Amyloid Precursor Protein Gene Family Members APLP-1 and APLP-2 Involves α-, β-, γ-, and ϵ-Like Cleavages

Eggert, S., Paliga, K., Soba, P., Evin, G. M., Masters, C. L., Weidemann, A., & Beyreuther, K. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311601200 · Cited by 209 · see citing works

Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves

Hu, X., He, W.-X., Diaconu, C., Tang, X., Kidd, G., Macklin, W., Trapp, B. D., & Yan, R. (2008) · The FASEB Journal · doi:10.1096/fj.08-106666 · Cited by 199 · see citing works

Identification of β-Secretase (BACE1) Substrates Using Quantitative Proteomics

Hemming, M. L., Elias, J. E., Gygi, S. P., & Selkoe, D. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008477 · Cited by 193 · see citing works

Deconstructing complexity: serial block-face electron microscopic analysis of the hippocampal mossy fiber synapse

Wilke, S. A., Antonios, J. K., Bushong, E. A., Badkoobehi, A., Malek, E., Hwang, M., Terada, M., Ellisman, M. H., & Ghosh, A. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1600-12.2013 · Cited by 179 · see citing works

Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies

Adalbert, R., Nogradi, A., Babetto, E., Janeckova, L., Walker, S. A., Kerschensteiner, M., Misgeld, T., & Coleman, M. P. (2009) · Brain · doi:10.1093/brain/awn312 · Cited by 177 · see citing works

Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease

Masliah, E., Hansen, L. A., Albright, T., Mallory, M. E., & Terry, R. D. (1991) · Acta Neuropathologica · doi:10.1007/bf00293464 · Cited by 174 · see citing works

The Neural Cell Adhesion Molecules L1 and CHL1 Are Cleaved by BACE1 Protease in Vivo*

Zhou, L., Barão, S., Laga, M., Bockstael, K., Borgers, M., Gijsen, H., Annaert, W., Moechars, D., Mercken, M., Gevaer, K., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.377465 · Cited by 172 · see citing works

Fine structural localization of acid phosphatase in senile plaques in Alzheimer's presenile dementia

Suzuki, K., & Terry, R. D. (1967) · Acta Neuropathologica · doi:10.1007/bf00688828 · Cited by 169 · see citing works

BACE Is Degraded via the Lysosomal Pathway

Koh, Y. H., Arnim, C. A. F. V., Hyman, B. T., Tanzi, R. E., & Tesco, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506199200 · Cited by 166 · see citing works

Endosomal sorting of readily releasable synaptic vesicles

Hoopmann, P., Punge, A., Barysch, S. V., Westphal, V., Bückers, J., Opazo, F., Bethani, I., Lauterbach, M. A., Hell, S. W., & Rizzoli, S. O. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007037107 · Cited by 166 · see citing works

Accumulation of autophagosomes after inhibition of hepatocytic protein degradation by vinblastine, leupeptin or a lysosomotropic amine

Kovács, A. L., Reith, A., & Seglen, P. O. (1982) · Experimental Cell Research · doi:10.1016/0014-4827(82)90020-9 · Cited by 163 · see citing works

BACE1 Deficiency Causes Altered Neuronal Activity and Neurodegeneration

Hu, X., Zhou, X., He, W., Yang, J., Xiong, W., Wong, P., Wilson, C. G., & Yan, R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1334-10.2010 · Cited by 162 · see citing works

β-Site Amyloid Precursor Protein (APP)-cleaving Enzyme 1 (BACE1)-deficient Mice Exhibit a Close Homolog of L1 (CHL1) Loss-of-function Phenotype Involving Axon Guidance Defects

Hitt, B. D., Riordan, S. M., Kukreja, L., Eimer, W. A., Rajapaksha, T. W., & Vassar, R. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.415505 · Cited by 150 · see citing works

Multiple events lead to dendritic spine loss in triple transgenic Alzheimer’s disease mice

Bittner, T., Fuhrmann, M., Burgold, S., Ochs, S. M., Hoffmann, N., Mitteregger, G., Kretzschmar, H., LaFerla, F. M., & Herms, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015477 · Cited by 149 · see citing works

Misguided Axonal Projections, Neural Cell Adhesion Molecule 180 mRNA Upregulation, and Altered Behavior in Mice Deficient for the Close Homolog of L1

Sallaz, M., Schachner, M., & Montag, D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.22.7967-7981.2002 · Cited by 148 · see citing works

Presenilin/γ-Secretase-mediated Cleavage of the Voltage-gated Sodium Channel β2-Subunit Regulates Cell Adhesion and Migration

Kim, D. Y., Ingano, L. A. M., Carey, B. W., Pettingell, W. H., & Kovacs, D. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412938200 · Cited by 146 · see citing works

Neuroprotective Secreted Amyloid Precursor Protein Acts by Disrupting Amyloid Precursor Protein Dimers

Gralle, M., Caarls, M. B., & Wouters, F. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808755200 · Cited by 138 · see citing works

β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment

Cai, J., Qi, X., Kociok, N., Skosyrski, S., Emilio, A., Ruan, Q., Han, S., Liu, L., Chen, Z., Bowes Rickman, C., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201101084 · Cited by 136 · see citing works

Autophagy, Mitochondria and Cell Death in Lysosomal Storage Diseases

Kiselyov, K., Jennings, J., Rbaibi, Y., & Chu, C. T. (2007) · Autophagy · doi:10.4161/auto.3906 · Cited by 134 · see citing works

Cell surface amyloid beta-protein precursor colocalizes with beta 1 integrins at substrate contact sites in neural cells.

Yamazaki, T., Koo, E. H., & Selkoe, D. J. (1997) · Europe PMC (PubMed Central) · doi:10.1523/jneurosci.17-03-01004.1997 · Cited by 133 · see citing works

β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus

Wu, J., Anwyl, R., & Rowan, M. J. (1995) · Neuroreport · doi:10.1097/00001756-199511270-00031 · Cited by 128 · see citing works

Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities

Hu, X., Shi, Q., Zhou, X., He, W., Yi, H. L., Yin, X., Gearing, M., Levey, A. I., & Yan, R. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601707 · Cited by 127 · see citing works

Deletion of the Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel Auxiliary Subunit TRIP8b Impairs HippocampalIhLocalization and Function and Promotes Antidepressant Behavior in Mice

Lewis, A. S., Vaidya, S. P., Blaiss, C. A., Liu, Z., Stoub, T. R., Brager, D. H., Chen, X., Bender, R. A., Estep, C. M., Popov, A. B., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0936-11.2011 · Cited by 123 · see citing works

Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in alzheimer's disease

Cummings, B. J., Su, J. H., Geddes, J. W., Van Nostrand, W. E., Wagner, S. L., Cunningham, D. D., & Cotman, C. W. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90265-4 · Cited by 120 · see citing works

β‐Secretase‐1 elevation in transgenic mouse models of Alzheimer’s disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development

Zhang, X., Cai, Y., Xiong, K., Cai, H., Luo, X., Feng, J., Clough, R. W., Struble, R. G., Patrylo, P. R., & Yan, X. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07017.x · Cited by 117 · see citing works

AP‐1/σ1B‐adaptin mediates endosomal synaptic vesicle recycling, learning and memory

Glyvuk, N., Tsytsyura, Y., Geumann, C., D’Hooge, R., Hüve, J., Kratzke, M., Baltes, J., Böning, D., Klingauf, J., & Schu, P. V. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.15 · Cited by 113 · see citing works

BACE1 gene deletion: Impact on behavioral function in a model of Alzheimer’s disease

Kobayashi, D., Zeller, M., Cole, T., Buttini, M., McConlogue, L., Sinha, S., Freedman, S., Morris, R. G. M., & Chen, K. S. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.002 · Cited by 111 · see citing works

BACE (β-secretase) modulates the processing of APLP2 in vivo

Pastorino, L., Ikin, A. F., Lamprianou, S., Vacaresse, N., Revelli, J., Platt, K. A., Paganetti, P., Mathews, P. M., Harroch, S., & Buxbaum, J. D. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.12.013 · Cited by 106 · see citing works

Re-Evaluation of the Structural Organization of Neuritic Plaques in Alzheimerʼs Disease

MASLIAH, E., MALLORY, M., DEERINCK, T., DETERESA, R., LAMONT, S., MILLER, A., TERRY, R. D., CARRAGHER, B., & ELLISMAN, M. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199311000-00009 · Cited by 105 · see citing works

Staging of Alzheimer's Pathology in Triple Transgenic Mice: A Light and Electron Microscopic Analysis

Oh, K.-J., Perez, S. E., Lagalwar, S., Vana, L., Binder, L., & Mufson, E. J. (2010) · International Journal of Alzheimer's Disease · doi:10.4061/2010/780102 · Cited by 105 · see citing works

Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP/PS1 hippocampus

Torres, M., Jiménez, S., Sanchez-Varo, R. M., Navarro, V., Trujillo‐Estrada, L., Sánchez‐Mejías, E., Carmona, I., Dávila, J. C., Vizuete, M., Gutiérrez, A., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-59 · Cited by 103 · see citing works

BACE1-/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization

Hitt, B. D., Jaramillo, T. C., Chetkovich, D. M., & Vassar, R. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-31 · Cited by 99 · see citing works

The Alzheimer's β-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb

Rajapaksha, T. W., Eimer, W. A., Bozza, T. C., & Vassar, R. J. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-88 · Cited by 98 · see citing works

A presynaptic endosomal trafficking pathway controls synaptic growth signaling

Rodal, A. A., Blunk, A. D., Akbergenova, Y., Jorquera, R. A., Buhl, L. K., & Littleton, J. T. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201009052 · Cited by 89 · see citing works

Neurodegenerative Changes Associated with β-Amyloid Deposition in the Brains of Mice Carrying Mutant Amyloid Precursor Protein and Mutant Presenilin-1 Transgenes

Kurt, M. A., Davies, D. C., Kidd, M., Duff, K., Rolph, S. C., JENNINGS, K. H., & Howlett, D. R. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7717 · Cited by 88 · see citing works

Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1

Boutajangout, A., Authelet, M., Blanchard, V., Touchet, N., Tremp, G. L., Pradier, L., & Brion, J. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.007 · Cited by 88 · see citing works

Evidence for Early Endosome‐like Fusion of Recently Endocytosed Synaptic Vesicles

Rizzoli, S. O., Bethani, I., Zwilling, D., Wenzel, D., Siddiqui, T. J., Brandhorst, D., & Jahn, R. (2006) · Traffic · doi:10.1111/j.1600-0854.2006.00466.x · Cited by 88 · see citing works

The precision of axon targeting of mouse olfactory sensory neurons requires the BACE1 protease

Cao, L., Rickenbacher, G. T., Rodriguez, S., Moulia, T. W., & Albers, M. W. (2012) · Scientific Reports · doi:10.1038/srep00231 · Cited by 84 · see citing works

Suppression of Cathepsins B and L Causes a Proliferation of Lysosomes and the Formation of Meganeurites in Hippocampus

Bednarski, E., Ribak, C. E., & LYNCH, G. S. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04006.1997 · Cited by 82 · see citing works

Primary lysosomal dysfunction causes cargo-specific deficits of axonal transport leading to Alzheimer-like neuritic dystrophy

Lee, S., Satō, Y., & Nixon, R. A. (2011) · Autophagy · doi:10.4161/auto.7.12.17956 · Cited by 81 · see citing works

β-amyloid-(1–40) increases long-term potentiation in rat hippocampus in vitro

Wu, J., Anwyl, R., & Rowan, M. J. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00539-w · Cited by 80 · see citing works

Identification and biology of β‐secretase

Kandalepas, P. C., & Vassar, R. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07512.x · Cited by 79 · see citing works

Synaptophysin and chromogranin A immunoreactivities in senile plaques of Alzheimer's disease

Brion, J., Couck, A., Bruce, M. T., Anderton, B. H., & Flament-Durand, J. (1991) · Brain Research · doi:10.1016/0006-8993(91)90697-t · Cited by 71 · see citing works

Reduced amyloid deposition in mice overexpressing RTN3 is adversely affected by preformed dystrophic neurites

Shi, Q., Prior, M., He, W.-X., Tang, X., Hu, X., & Yan, R. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5741-08.2009 · Cited by 65 · see citing works

β‐Secretase‐1 elevation in aged monkey and Alzheimer’s disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β‐amyloid accumulation

Cai, Y., Xiong, K., Zhang, X., Cai, H., Luo, X., Feng, J., Clough, R. W., Struble, R. G., Patrylo, P. R., Chu, Y., et al. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07376.x · Cited by 64 · see citing works

Qualitative and Quantitative Differences in Senile Plaque Dystrophie Neurites of Alzheimerʼs Disease and Normal Aged Brain

WANG, D., & Muñoz, D. G. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199507000-00009 · Cited by 62 · see citing works

Subcellular localization of amyloid precursor protein in senile plaques of Alzheimer's disease.

Kawai, M., Cras, P. P., Richey, P. L., Tabaton, M., Lowery, D. E., Gonzalez‐DeWhitt, P. A., Greenberg, B., Gambetti, P. L., & Perry, G. L. (1992) · PubMed Central · Cited by 59 · see citing works

Regulation of neuronal function by protein trafficking: a role for the endosomal pathway

Buckley, K. M., Melikian, H. E., Provoda, C. J., & Waring, M. T. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.t01-2-00011.x · Cited by 59 · see citing works

The β-amyloid-related proteins presenilin 1 and BACE1 are axonally transported to nerve terminals in the brain

Sheng, J. G., Price, D. L., & Koliatsos, V. E. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.08.018 · Cited by 58 · see citing works

Targeting of the Synaptic Vesicle Protein Synaptobrevin in the Axon of Cultured Hippocampal Neurons: Evidence for Two Distinct Sorting Steps

West, A. E., Neve, R. L., & Buckley, K. M. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.4.917 · Cited by 57 · see citing works

Lysosomal Protease Inhibitors Induce Meganeurites and Tangle-like Structures in Entorhinohippocampal Regions Vulnerable to Alzheimer's Disease

Bi, X., Zhou, J., & LYNCH, G. S. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7087 · Cited by 57 · see citing works

Amyloid β Protein Modulates Glutamate-Mediated Neurotransmission in the Rat Basal Forebrain: Involvement of Presynaptic Neuronal Nicotinic Acetylcholine and Metabotropic Glutamate Receptors

Chin, J. H., Ma, L., MacTavish, D., & Jhamandas, J. H. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1843-07.2007 · Cited by 56 · see citing works

Ultrastructure of mossy fiber endings in in vitro hippocampal slices

Frotscher, M., Misgeld, U., & Nitsch, C. (1981) · Experimental Brain Research · doi:10.1007/bf00238881 · Cited by 51 · see citing works

The amyloid precursor protein of Alzheimer's disease is found on the surface of static but not actively motile portions of neurites

Storey, E., Spurck, T. P., Pickett‐Heaps, J. D., Beyreuther, K. T., & Masters, C. L. (1996) · Brain Research · doi:10.1016/0006-8993(96)00609-9 · Cited by 50 · see citing works

An extensive network of PHFτ‐rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease

Schmidt, M. L., Didario, A. G., Lee, V. M. ‐., & Trojanowski, J. Q. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00259-2 · Cited by 47 · see citing works

Abnormal axonal guidance and brain anatomy in mouse mutants for the cell recognition molecules close homolog of L1 and NgCAM-related cell adhesion molecule

Heyden, A., Angenstein, F., Sallaz, M., Seidenbecher, C. I., & Montag, D. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.04.080 · Cited by 44 · see citing works

Levels of kinesin light chain and dynein intermediate chain are reduced in the frontal cortex in Alzheimer’s disease: implications for axoplasmic transport

Morel, M., Héraud, C., Nicaise, C., Suain, V., & Brion, J. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0901-4 · Cited by 43 · see citing works

The Occurrence of Aging-Dependent Reticulon 3 Immunoreactive Dystrophic Neurites Decreases Cognitive Function

Shi, Q., Hu, X., Prior, M., & Yan, R. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5887-08.2009 · Cited by 31 · see citing works

Regulation of Axonal HCN1 Trafficking in Perforant Path Involves Expression of Specific TRIP8b Isoforms

Wilkars, W., Liu, Z., Lewis, A. S., Stoub, T. R., Ramos, E. M., Brandt, N., Nicholson, D. A., Chetkovich, D. M., & Bender, R. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032181 · Cited by 30 · see citing works

RTN/Nogo in forming Alzheimer's neuritic plaques

Prior, M., Shi, Q., Hu, X., He, W., Levey, A. I., & Yan, R. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.01.017 · Cited by 21 · see citing works

Evidence for a Primary Endocytic Vesicle Involved in Synaptic Vesicle Biogenesis

Provoda, C. J., Waring, M. T., & Buckley, K. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7004 · Cited by 20 · see citing works

Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease.

Dikranian, K. T., Kim, J., Stewart, F. R., Levy, M. A., & Holtzman, D. M. (2012) · Europe PMC (PubMed Central) · Cited by 17 · see citing works

O1‐02‐06: The Alzheimer's beta‐secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb

Rajapaksha, T., & Vassar, R. J. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.213 · Cited by 16 · see citing works

Dynamics of Presynaptic Endosomes Produced during Transmitter Release

Kadota, T., MIZOTE, M., & Kadota, K. (1994) · Journal of Electron Microscopy · doi:10.1093/oxfordjournals.jmicro.a051087 · Cited by 10 · see citing works

The Amyloid-β Pathway in Alzheimer’s Disease

Hampel, H., Hardy, J., Blennow, K., Chen, C., Perry, G., Kim, S. H., Villemagne, V. L., Aisen, P., Vendruscolo, M., Iwatsubo, T., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01249-0 · Cited by 1,952 · see citing works

The β-Secretase BACE1 in Alzheimer’s Disease

Hampel, H., Vassar, R., De Strooper, B., Hardy, J., Willem, M., Singh, N., Zhou, J., Yan, R., Vanmechelen, E., De Vos, A., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.001 · Cited by 694 · see citing works

Targeting the β secretase BACE1 for Alzheimer's disease therapy

Yan, R., & Vassar, R. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70276-x · Cited by 628 · see citing works

Update on Alzheimer’s Disease Therapy and Prevention Strategies

Graham, W. V., Bonito-Oliva, A., & Sakmar, T. P. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-042915-103753 · Cited by 506 · see citing works

Drug candidates in clinical trials for Alzheimer’s disease

Hung, S.-Y., & Fu, W.-M. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0355-7 · Cited by 420 · see citing works

BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease

Vassar, R. J. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0089-7 · Cited by 413 · see citing works

Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer’s disease amyloid plaques

Gowrishankar, S., Yuan, P., Wu, Y., Schrag, M., Paradise, S., Grutzendler, J., De Camilli, P., & Ferguson, S. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510329112 · Cited by 406 · see citing works

BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease

Ghosh, A. K., & Osswald, H. L. (2014) · Chemical Society Reviews · doi:10.1039/c3cs60460h · Cited by 361 · see citing works

Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects

Vassar, R. J., Kuhn, P., Haass, C., Kennedy, M. E., Rajendran, L., Wong, P. C., & Lichtenthaler, S. F. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12715 · Cited by 329 · see citing works

Proteolytic ectodomain shedding of membrane proteins in mammals—hardware, concepts, and recent developments

Lichtenthaler, S. F., Lemberg, M. K., & Fluhrer, R. (2018) · The EMBO Journal · doi:10.15252/embj.201899456 · Cited by 298 · see citing works

Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease

Sadleir, K. R., Kandalepas, P. C., Buggia-Prévot, V., Nicholson, D. A., Thinakaran, G., & Vassar, R. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1558-9 · Cited by 294 · see citing works

Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer’s disease pathology and cognitive symptoms

Li, P., Marshall, L., Oh, G., Jakubowski, J. L., Groot, D., He, Y., Wang, T., Petronis, A., & Labrie, V. (2019) · Nature Communications · doi:10.1038/s41467-019-10101-7 · Cited by 234 · see citing works

Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level

Sadleir, K. R., Eimer, W. A., Cole, S. L., & Vassar, R. (2015) · Molecular Neurodegeneration · doi:10.1186/1750-1326-10-1 · Cited by 213 · see citing works

The alpha secretase ADAM10: A metalloprotease with multiple functions in the brain

Säftig, P., & Lichtenthaler, S. F. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.10.003 · Cited by 209 · see citing works

A Close Look at BACE1 Inhibitors for Alzheimer’s Disease Treatment

Das, B., & Yan, R. (2019) · CNS Drugs · doi:10.1007/s40263-019-00613-7 · Cited by 169 · see citing works

Axonal BACE1 dynamics and targeting in hippocampal neurons: a role for Rab11 GTPase

Buggia-Prévot, V., Fernandez, C., Riordan, S. M., Vetrivel, K. S., Roseman, J., Waters, J., Bindokas, V. P., Vassar, R. J., & Thinakaran, G. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-1 · Cited by 201 · see citing works

Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway

Das, U., Wang, L., Ganguly, A., Saikia, J. M., Wagner, S. L., Koo, E. H., & Roy, S. (2015) · Nature Neuroscience · doi:10.1038/nn.4188 · Cited by 189 · see citing works

Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer’s disease

Landel, V., Baranger, K., Virard, I., Loriod, B., Khrestchatisky, M., Rivera, S., Benech, P., & Féron, F. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-33 · Cited by 176 · see citing works

BACE1 Physiological Functions May Limit Its Use as Therapeutic Target for Alzheimer's Disease.

Barão, S., Moechars, D., Lichtenthaler, S., & de Strooper, B. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.01.003 · Cited by 161 · see citing works

Endo‐lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?

Whyte, L. S., Lau, A. A., Hemsley, K. M., Hopwood, J. J., & Sargeant, T. J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13935 · Cited by 150 · see citing works

Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins

Čermak, S., Košiček, M., Mladenović, A., Smiljanić, K., Kanazir, S., & Hecimovic, S. K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167428 · Cited by 148 · see citing works

Therapeutic Strategies Targeting Amyloid-β in Alzheimer’s Disease

Pinheiro, L. M. V., & Faustino, C. M. C. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190321163438 · Cited by 142 · see citing works

Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis

Mahan, T. E., Wang, C., Bao, X., Choudhury, A., Ulrich, J. D., & Holtzman, D. M. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00516-0 · Cited by 134 · see citing works

Investigational BACE inhibitors for the treatment of Alzheimer’s disease

Imbimbo, B. P., & Watling, M. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1683160 · Cited by 132 · see citing works

Pharmacological Inhibition of BACE1 Impairs Synaptic Plasticity and Cognitive Functions

Filser, S., Ovsepian, S. V., Masana, M., Blázquez‐Llorca, L., Elvang, A. B., Volbracht, C., Müller, M. B., Jung, C. K. E., & Herms, J. W. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.013 · Cited by 131 · see citing works

Synaptic Loss in Alzheimer's Disease: Mechanistic Insights Provided by Two-Photon in vivo Imaging of Transgenic Mouse Models

Subramanian, J., Savage, J. C., & Tremblay, M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592607 · Cited by 124 · see citing works

Roles of eIF2α kinases in the pathogenesis of Alzheimer’s disease

Ohno, M. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00022 · Cited by 121 · see citing works

Impaired JIP3-dependent axonal lysosome transport promotes amyloid plaque pathology

Gowrishankar, S., Wu, Y., & Ferguson, S. M. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201612148 · Cited by 123 · see citing works

Role of BACE1 in Alzheimer’s synaptic function

Das, B., & Yan, R. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0093-5 · Cited by 122 · see citing works

Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer's disease

Liu, Y., Zhou, H., Yin, T., Gong, Y., Yuan, G., Chen, L., & Liu, J. (2019) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2019.05.066 · Cited by 111 · see citing works

Defining the earliest pathological changes of Alzheimer's disease

Vickers, J. C., Mitew, S., Woodhouse, A., Fernández-Martos, C. M., Kirkcaldie, M. T., Canty, A. J., McCormack, G. H., & King, A. E. (2015) · Current Alzheimer Research · doi:10.2174/1567205013666151218150322 · Cited by 108 · see citing works

Precision pharmacology for Alzheimer’s disease

Hampel, H. J., Vergallo, A., Aguilar, L. F., Benda, N., Broich, K., Cuello, A. C., Cummings, J. L., Dubois, B., Federoff, H. J., Fiandaca, M. S., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.014 · Cited by 112 · see citing works

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease

Balmik, A. A., & Chinnathambi, S. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00732-z · Cited by 108 · see citing works

Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6

Zhu, K., Xiang, X., Filser, S., Marinković, P., Dorostkar, M. M., Crux, S., Neumann, U., Shimshek, D. R., Rammes, G., Haass, C., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.12.023 · Cited by 107 · see citing works

Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery

Mateus, A., Gordon, L. J., Wayne, G. J., Almqvist, H., Axelsson, H., Seashore-Ludlow, B. A., Treyer, A., Matsson, P., Lundbäck, T., West, A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701848114 · Cited by 106 · see citing works

Physiological Functions of the β-Site Amyloid Precursor Protein Cleaving Enzyme 1 and 2

Yan, R. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00097 · Cited by 105 · see citing works

Evidence for Alzheimer’s disease-linked synapse loss and compensation in mouse and human hippocampal CA1 pyramidal neurons

Neuman, K. M., Molina-Campos, E., Musial, T. F., Price, A. L., Oh, K.-J., Wolke, M. L., Buss, E. W., Scheff, S. W., Mufson, E. J., & Nicholson, D. A. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0848-z · Cited by 100 · see citing works

Aquaporin-4 reduces neuropathology in a mouse model of Alzheimer’s disease by remodeling peri-plaque astrocyte structure

Smith, A. J., Duan, T., & Verkman, A. S. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0728-0 · Cited by 98 · see citing works

Neuronally-directed effects of RXR activation in a mouse model of Alzheimer’s disease

Mariani, M. M., Malm, T., Lamb, R., Jay, T. R., Neilson, L., Casali, B., Medarametla, L., & Landreth, G. E. (2017) · Scientific Reports · doi:10.1038/srep42270 · Cited by 98 · see citing works

Chronic sleep fragmentation shares similar pathogenesis with neurodegenerative diseases: Endosome‐autophagosome‐lysosome pathway dysfunction and microglia‐mediated neuroinflammation

Xie, Y., Ba, L., Wang, M., Deng, S., Chen, S., Huang, L., Zhang, M., Wang, W., & Ding, F. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13218 · Cited by 100 · see citing works

Targeted BACE-1 inhibition in microglia enhances amyloid clearance and improved cognitive performance

Singh, N., Das, B., Zhou, J., Hu, X., & Yan, R. (2022) · Science Advances · doi:10.1126/sciadv.abo3610 · Cited by 95 · see citing works

Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice

Ou-Yang, M.-H., Kurz, J. E., Nomura, T., Popovic, J., Rajapaksha, T. W., Dong, H., Contractor, A., Chetkovich, D. M., Tourtellotte, W. G., & Vassar, R. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao5620 · Cited by 94 · see citing works

EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimerʼns disease

Tai, L. M., Balu, D., Avila-Munoz, E., Abdullah, L., Thomas, R., Collins, N., Valencia-Olvera, A. C., & LaDu, M. J. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r076315 · Cited by 93 · see citing works

BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology

Peters, F., Salihoglu, H., Rodrigues, E. F., Herzog, É., Blume, T., Filser, S., Dorostkar, M. M., Shimshek, D. R., Brose, N., Neumann, U., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1804-9 · Cited by 86 · see citing works

Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions

Kizuka, Y., Nakano, M., Kitazume, S., Saito, T., Saido, T. C., & Taniguchi, N. (2015) · Biochemical Journal · doi:10.1042/bj20150607 · Cited by 89 · see citing works

Physiological Roles of β-amyloid in Regulating Synaptic Function: Implications for AD Pathophysiology

Cai, W., Li, L., Sang, S., Pan, X., & Zhong, C. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-022-00985-9 · Cited by 83 · see citing works

ADAM10 and BACE1 are localized to synaptic vesicles

Lundgren, J. L., Ahmed, S., Schedin‐Weiss, S., Gouras, G. K., Winblad, B. G., Tjernberg, L. O., & Frykman, S. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13287 · Cited by 82 · see citing works

Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs

Lozupone, M., Solfrizzi, V., D’Urso, F., Di Gioia, I., Sardone, R., Dibello, V., Stallone, R., Liguori, A., Ciritella, C., Daniele, A., et al. (2020) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2020.1808621 · Cited by 77 · see citing works

Lipolysaccharide-Induced Neuroinflammation Is Associated with Alzheimer-Like Amyloidogenic Axonal Pathology and Dendritic Degeneration in Rats

Deng, X., Li, M., Ai, W., He, L., Lu, D., Patrylo, P. R., Cai, H., Luo, X., Li, Z., & Yan, X. (2014) · Advances in Alzheimer s Disease · doi:10.4236/aad.2014.32009 · Cited by 75 · see citing works

Presynaptic failure in Alzheimer's disease

Barthet, G., & Mulle, C. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101801 · Cited by 74 · see citing works

Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer’s disease

Andrew, R. J., Fernandez, C. G., Stanley, M., Jiang, H., Nguyen, P. A. H., Rice, R. C., Buggia-Prévot, V., Rossi, P. D., Vetrivel, K. S., Lamb, R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708568114 · Cited by 73 · see citing works

Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice

Liu, L., Liu, Y., Li, N., Huang, R., Zheng, X., Huang, L., Hou, S.-X., & Yuan, Q. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.01.003 · Cited by 70 · see citing works

Autophagy as a molecular target of quercetin underlying its protective effects in human diseases

Ashrafizadeh, M., Ahmadi, Z., Farkhondeh, T., & Samarghandian, S. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1671458 · Cited by 71 · see citing works

Trehalose against Alzheimer's Disease: Insights into a Potential Therapy

Khalifeh, M., Read, M. I., Barreto, G. E., & Sahebkar, A. (2020) · BioEssays · doi:10.1002/bies.201900195 · Cited by 65 · see citing works

Impact of RTN3 Deficiency on Expression of BACE1 and Amyloid Deposition

Shi, Q., Ge, Y., Sharoar, M. G., He, W., Xiang, R., Zhang, Z., Hu, X., & Yan, R. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1588-14.2014 · Cited by 67 · see citing works

Molecular Differences and Similarities between Alzheimer's Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis

Maarouf, C. L., Kokjohn, T. A., Whiteside, C. M., Macias, M. P., Kalback, W. M., Sabbagh, M. N., Beach, T. G., Vassar, R. J., & Roher, A. E. (2013) · Biochemistry Insights · doi:10.4137/bci.s13025 · Cited by 66 · see citing works

APP Is Cleaved by Bace1 in Pre-Synaptic Vesicles and Establishes a Pre-Synaptic Interactome, via Its Intracellular Domain, with Molecular Complexes that Regulate Pre-Synaptic Vesicles Functions

Prete, D. D., Lombino, F. L., Liu, X., & D'adamio, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108576 · Cited by 62 · see citing works

Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease

Ye, X., Feng, T., Tammineni, P., Chang, Q., Jeong, Y. Y., Margolis, D. J., Cai, H., Kusnecov, A. W., & Cai, Q. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2851-16.2017 · Cited by 62 · see citing works

Mitigating Alzheimer’s Disease with Natural Polyphenols: A Review

Gaudreault, R., & Mousseau, N. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190315093520 · Cited by 63 · see citing works

Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progression

Liebsch, F., Kulic, L., Teunissen, C. E., Shobo, A., Ulku, I., Engelschalt, V., Hancock, M. A., van der Flier, W. M., Kunach, P., Rosa‐Neto, P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10152-w · Cited by 64 · see citing works

APP accumulates with presynaptic proteins around amyloid plaques: A role for presynaptic mechanisms in Alzheimer's disease?

Jordà‐Siquier, T., Petrel, M., Kouskoff, V., Smailovic, U., Cordelières, F., Frykman, S., Müller, U., Mulle, C., & Barthet, G. (2022) · Alzheimer's &amp; Dementia · doi:10.1002/alz.12546 · Cited by 63 · see citing works

Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice

Kidana, K., Tatebe, T., Ito, K., Hara, N., Kakita, A., Saito, T., Takatori, S., Ouchi, Y., Ikeuchi, T., Makino, M., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708184 · Cited by 61 · see citing works

The synthetic TRPML1 agonist ML-SA1 rescues Alzheimer-related alterations of the endosomal-autophagic-lysosomal system

Somogyi, A., Kirkham, E. D., Lloyd‐Evans, E., Winston, J., Allen, N. D., Mackrill, J. J., Anderson, K. E., Hawkins, P. T., Gardiner, S. E., Waller‐Evans, H., et al. (2023) · Journal of Cell Science · doi:10.1242/jcs.259875 · Cited by 63 · see citing works

Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer’s Therapeutics

Mouchlis, V. D., Melagraki, G., Zacharia, L. C., & Afantitis, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030703 · Cited by 63 · see citing works

Functions of the Alzheimer’s Disease Protease BACE1 at the Synapse in the Central Nervous System

Munro, K. M., Nash, A., Pigoni, M., Lichtenthaler, S. F., & Gunnersen, J. M. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0800-1 · Cited by 55 · see citing works

The Normal and Pathologic Roles of the Alzheimer's β-secretase, BACE1

Kandalepas, P. C., & Vassar, R. J. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140604122059 · Cited by 55 · see citing works

Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease

Moussa, C. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1369527 · Cited by 46 · see citing works

Increased Expression of Reticulon 3 in Neurons Leads to Reduced Axonal Transport of β Site Amyloid Precursor Protein-cleaving Enzyme 1

Deng, M., He, W., Tan, Y., Han, H., Hu, X., Xia, K., Zhang, Z., & Yan, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.480079 · Cited by 53 · see citing works

Neurological dysfunctions associated with altered BACE 1‐dependent Neuregulin‐1 signaling

Hu, X., Fan, Q., Hou, H., & Yan, R. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13395 · Cited by 52 · see citing works

The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer’s Disease

Vos, A. D., Struyfs, H., Jacobs, D., Fransén, E., Klewansky, T., Roeck, E. E. D., Robberecht, C., Broeckhoven, C. V., Duyckaerts, C. J., Engelborghs, S., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160227 · Cited by 52 · see citing works

The Emerging Roles of the β-Secretase BACE1 and the Long Non-coding RNA BACE1-AS in Human Diseases: A Focus on Neurodegenerative Diseases and Cancer

Sayad, A., Najafi, S., Hussen, B. M., Abdullah, S. T., Movahedpour, A., Taheri, M. N., & Hajiesmaeili, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.853180 · Cited by 53 · see citing works

Consequences of Pharmacological BACE Inhibition on Synaptic Structure and Function

Zhu, K., Peters, F., Filser, S., & Herms, J. W. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.04.022 · Cited by 50 · see citing works

BACE1 SUMOylation increases its stability and escalates the protease activity in Alzheimer’s disease

Bao, J., Qin, M., Mahaman, Y. A. R., Zhang, B., Huang, F., Zeng, K., Xia, Y., Ke, D., Wang, Q., Liu, R., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800498115 · Cited by 50 · see citing works

Dysfunctional tubular endoplasmic reticulum constitutes a pathological feature of Alzheimer’s disease

Sharoar, M. G., Shi, Q., Ge, Y., He, W., Hu, X., Perry, G. L., Zhu, X., & Yan, R. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.181 · Cited by 50 · see citing works

Alzheimer's therapy targeting the β-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies.

Ohno, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.007 · Cited by 43 · see citing works

BACE1 controls synaptic function through modulating release of synaptic vesicles

Das, B., Singh, N., Yao, A. Y., Zhou, J., He, W., Hu, X., & Yan, R. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01166-2 · Cited by 49 · see citing works

Neuronal spreading and plaque induction of intracellular Aβ and its disruption of Aβ homeostasis

Roos, T. T., Garcia, M. G., Martinsson, I., Mabrouk, R., Israelsson, B., Deierborg, T., Kobro‐Flatmoen, A., Tanila, H., & Gouras, G. K. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02345-9 · Cited by 47 · see citing works

The Alzheimer’s disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130

Müller, S. A., Shmueli, M. D., Feng, X. M., Tüshaus, J., Schumacher, N., Clark, R., Smith, B. E., Chi, A., Rose‐John, S., Kennedy, M. E., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00596-6 · Cited by 49 · see citing works

Future Therapeutics in Alzheimer’s Disease: Development Status of BACE Inhibitors

Evin, G. M. (2016) · BioDrugs · doi:10.1007/s40259-016-0168-3 · Cited by 49 · see citing works

Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aβ

Meilandt, W. J., Maloney, J. A., Imperio, J., Lalehzadeh, G., Earr, T., Crowell, S., Bainbridge, T. W., Lu, Y., Ernst, J. A., Fuji, R. N., et al. (2019) · Alzheimer's Research &amp; Therapy · doi:10.1186/s13195-019-0553-5 · Cited by 45 · see citing works

Amyloid Plaques of Alzheimer’s Disease as Hotspots of Glutamatergic Activity

Ovsepian, S. V., O’Leary, V. B., Záborszky, L., Ntziachristos, V., & Dolly, J. O. (2018) · The Neuroscientist · doi:10.1177/1073858418791128 · Cited by 45 · see citing works

Synaptotagmins interact with APP and promote Aβ generation

Gautam, V., D’Avanzo, C., Berezovska, O., Tanzi, R. E., & Kovacs, D. M. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0028-5 · Cited by 44 · see citing works

Role of long noncoding RNAs in malignant disease (Review)

Li, Y., & Wang, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4711 · Cited by 44 · see citing works

Lysosomal <scp>LAMP</scp>1 immunoreactivity exists in both diffuse and neuritic amyloid plaques in the human hippocampus

Hassiotis, S., Manavis, J., Blumbergs, P. C., Hattersley, K. J., Carosi, J. M., Kamei, M., & Sargeant, T. J. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13913 · Cited by 44 · see citing works

In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer’s disease pathology

Trujillo‐Estrada, L., Jiménez, S., Castro, V. D., Torres, M., Baglietto‐Vargas, D., Moreno‐González, I., Navarro, V., Sanchez-Varo, R. M., Sánchez‐Mejías, E., Dávila, J. C., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-73 · Cited by 43 · see citing works

Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer’s disease

Wang, T., Sobue, A., Watanabe, S., Komine, O., Saido, T. C., Saito, T., & Yamanaka, K. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03046-2 · Cited by 48 · see citing works

Tau deletion reduces plaque‐associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease

Peters, F., Salihoglu, H., Pratsch, K., Herzog, É., Pigoni, M., Sgobio, C., Lichtenthaler, S. F., Neumann, U., & Herms, J. W. (2019) · The EMBO Journal · doi:10.15252/embj.2019102345 · Cited by 43 · see citing works

Investigation of flap flexibility of β-secretase using molecular dynamic simulations

Kumalo, H. M., Bhakat, S., & Soliman, M. E. S. (2015) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2015.1064831 · Cited by 42 · see citing works

β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification

Hampel, H. J., Lista, S., Vanmechelen, E., Zetterberg, H., Giorgi, F. S., Galgani, A., Blennow, K., Caraci, F., Das, B., Yan, R., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00686-3 · Cited by 42 · see citing works

MiR-16 attenuates β-amyloid-induced neurotoxicity through targeting β-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer’s disease cell model

Zhong, Z., Yuan, K., Tong, X., Hu, J., Song, Z., Zhang, G., Fang, X., & Zhang, W. (2018) · Neuroreport · doi:10.1097/wnr.0000000000001118 · Cited by 41 · see citing works

Guanidine-based β amyloid precursor protein cleavage enzyme 1 (BACE-1) inhibitors for the Alzheimer's disease (AD): A review

Gehlot, P., Kumar, S., Vyas, V. K., Choudhary, B. S., Sharma, M., & Malik, R. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.117047 · Cited by 40 · see citing works

Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase

Schweig, J. E., Yao, H., Beaulieu‐Abdelahad, D., Ait‐Ghezala, G., Mouzon, B., Crawford, F., MULLAN, M. J., & Paris, D. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0472-2 · Cited by 39 · see citing works

Identification of rare RTN3 variants in Alzheimer’s disease in Han Chinese

Zou, Y., He, W., Wang, K., Han, H., Xiao, T., Chen, X., Zhou, B., Tan, J., Xia, K., Tang, B., et al. (2018) · Human Genetics · doi:10.1007/s00439-018-1868-1 · Cited by 40 · see citing works

A New Fluorogenic Small-Molecule Labeling Tool for Surface Diffusion Analysis and Advanced Fluorescence Imaging of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Based on Silicone Rhodamine: SiR-BACE1

Karch, S., Broichhagen, J., Schneider, J., Böning, D., Hartmann, S., Schmid, B., Tripal, P., Palmisano, R., Alzheimer, C., Johnsson, K., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00387 · Cited by 39 · see citing works

Amyloid β-protein oligomers upregulate the β-secretase, BACE1, through a post-translational mechanism involving its altered subcellular distribution in neurons

Mamada, N., Tanokashira, D., Hosaka, A., Kametani, F., Tamaoka, A., & Araki, W. (2015) · Molecular Brain · doi:10.1186/s13041-015-0163-5 · Cited by 39 · see citing works

Brain‐targeted co‐delivery of β‐amyloid converting enzyme 1 shRNA and epigallocatechin‐3‐gallate by multifunctional nanocarriers for Alzheimer's disease treatment

Lv, L., Yang, F., Li, H., & Yuan, J. (2020) · IUBMB Life · doi:10.1002/iub.2330 · Cited by 39 · see citing works

Genetic Inhibition of Phosphorylation of the Translation Initiation Factor eIF2α Does Not Block Aβ-Dependent Elevation of BACE1 and APP Levels or Reduce Amyloid Pathology in a Mouse Model of Alzheimer’s Disease

Sadleir, K. R., Eimer, W. A., Kaufman, R. J., Osten, P., & Vassar, R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101643 · Cited by 38 · see citing works

Differential spatial expression of peripheral olfactory neuron-derived BACE1 induces olfactory impairment by region-specific accumulation of β-amyloid oligomer

Yoo, S., Lee, J., Kim, S. Y., Son, G., Kim, J. Y., Cho, B., Yu, S., Chang, K., Suh, Y., & Moon, C. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.349 · Cited by 38 · see citing works

Synaptic dysfunction in Alzheimer's disease: From the role of amyloid β-peptide to the α-secretase ADAM10

Musardo, S., & Marcello, E. E. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.06.018 · Cited by 37 · see citing works

A combination Alzheimer’s therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice

Devi, L., & Ohno, M. (2015) · Molecular Brain · doi:10.1186/s13041-015-0110-5 · Cited by 34 · see citing works

β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer's Disease Pathogenesis

Zhao, J., Fu, Y., Yasvoina, M., Shao, P., Hitt, B., O'Connor, T., Logan, S., Maus, E., Citron, M., Berry, R., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4396-06.2007 · Cited by 365 · see citing works

β‐Secretase‐1 elevation in aged monkey and Alzheimer’s disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β‐amyloid accumulation

Cai, Y., Xiong, K., Zhang, X., Cai, H., Luo, X., Feng, J., Clough, R. W., Struble, R. G., Patrylo, P. R., Chu, Y., et al. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07376.x · Cited by 64 · see citing works

P1-160 The role of the tissue-type plasminogen activator in the course of amyloid accumulation

Cacquevel, M., Chéenne, S., Castel, H., Bénavidès, J., Pradier, L., & Vivien, D. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(04)80473-1

β‐Secretase‐1 elevation in transgenic mouse models of Alzheimer’s disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development

Zhang, X., Cai, Y., Xiong, K., Cai, H., Luo, X., Feng, J., Clough, R. W., Struble, R. G., Patrylo, P. R., & Yan, X. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07017.x · Cited by 117 · see citing works

Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains

Harada, H., Tamaoka, A., Ishii, K., Shoji, S., Kametaka, S., Kametani, F., Saito, Y., & Murayama, S. (2005) · Neuroscience Research · doi:10.1016/j.neures.2005.10.001 · Cited by 62 · see citing works